Quest Diagnostics Inc (DGX)

DGX on New York Consolidated

59.40USD
11 Jul 2014
Price Change (% chg)

$0.36 (+0.61%)
Prev Close
$59.04
Open
$59.03
Day's High
$59.46
Day's Low
$58.56
Volume
696,171
Avg. Vol
1,843,427
52-wk High
$64.10
52-wk Low
$50.46

DGX

Chart for DGX

About

Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide... (more)

Overall

Beta: 0.71
Market Cap (Mil.): $8,582.43
Shares Outstanding (Mil.): 144.49
Dividend: 0.33
Yield (%): 2.22

Financials

  DGX Industry Sector
P/E (TTM): 11.08 30.78 35.77
EPS (TTM): 5.36 -- --
ROI: 10.18 8.16 18.27
ROE: 19.51 13.05 19.16
Search Stocks

French biotechs court U.S. investors amid wave of IPOs

PARIS - Eighteen French biotech firms, several newly listed on the Paris stock market, head to New York on Wednesday and Thursday to convince U.S. investors to help fund the next stages of their research and development.

25 Jun 2014

Quest Diagnostics quarterly profit misses estimates

- Laboratory tests provider Quest Diagnostics Inc's first-quarter adjusted profit fell short of analysts' expectations, as an unusually harsh U.S. winter deterred people from going to its centers for tests.

24 Apr 2014

Quest Diagnostics quarterly profit misses estimates

April 24 - Laboratory tests provider Quest Diagnostics Inc's first-quarter adjusted profit fell short of analysts' expectations, as an unusually harsh U.S. winter deterred people from going to its centers for tests.

24 Apr 2014

Deals of the day- Mergers and acquisitions

(Adds Grupo Bimbo, Loral Space, Vapores, Unilever, Marriott, Quest, Cosumar)

22 Jan 2014

Quest Diagnostics to buy Solstas for $570 mln

Jan 22 - Quest Diagnostics Inc, a provider of laboratory test services, said it would buy Solstas Lab Partners Group for about $570 million to expand into the U.S. Southeast.

22 Jan 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks